MetLife Securities' Largest Q3 Healthcare Stock Investments: ABT, JNJ, PFE, NVS Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Healthspring Inc. (NYSE:HS): On 06/30/2011, MetLife Securities ... |
